Richmond City Health District

Everyone age 6 months and older can now get a vaccine!
Attend an RHHD Vaccination Clinic.
It’s free, easy, and safe.

Language translations and TTY services are available at 1-877-VAX-IN-VA (1-877-829-4682), 8:00 AM to 6:00 PM Monday-Friday
Servicios de traducción y teléfonos de texto (TTY) están disponibles: 1-877-VAX-IN-VA (1-877-829-4682), 8:00 AM–8:00 PM lunes a viernes. 

Questions?
Call the RHHD Call center: (804) 205.3501

Press Releases

RHHD & RPS COLLABORATE TO PROVIDE IN-SCHOOL IMMUNIZATION CLINICS

RICHMOND, VA — The Richmond and Henrico Health Districts (RHHD) and Richmond Public Schools (RPS) are partnering to offer in-school immunization clinics in February and March. RPS families are encouraged to sign the RPS-provided consent form and have their 6th and 11th graders receive their school-required immunizations ahead of the traditional Back-to-School season... [Read full Feb 20, 2024 Press Release]

RHHD COMMEMORATES NATIONAL BLACK HIV/AIDS AWARENESS DAY FEB. 7

RICHMOND, VA —Richmond and Henrico Health Districts (RHHD) commemorate National Black HIV/AIDS Awareness Day on Wednesday, Feb. 7 by encouraging Black Richmond and Henrico residents to get tested and seek treatment. This day also creates the opportunity for healthcare providers and policy makers to reflect on the ways racism, discrimination, and mistrust in the health care system may affect those seeking and receiving HIV prevention and treatment services. 

This year’s NBHAAD theme is “Engage, Educate, Empower: Uniting to End HIV/AIDS in Black Communities.” This theme focuses on amplifying the dialogue around HIV/AIDS... [Read full Feb 7, 2024 Press Release]

RHHD ENCOURAGES PREGNANT PEOPLE AND THOSE OVER 60 TO SCHEDULE APPOINTMENTS TO RECEIVE THE RSV VACCINE

DECEMBER 14, 2023 —The Richmond and Henrico Health Districts (RHHD) encourage pregnant people and those 60 and older to talk with their health care provider about scheduling an appointment to receive ABRYSVO, an injectable vaccine for Respiratory Syncytial Virus (RSV) that can prevent associated lower respiratory tract disease (LRTD).

ABRYSVO is approved for use at 32 through 36 weeks gestational age of pregnancy and can prevent LRTD and severe LRTD caused by RSV in infants from birth through 6 months of age...[Read full Dec 14, 2024 Press Release]

Find Local Resources

Need help? Search free and reduced-cost services like medical care, food, housing, and more in your area.